SONOSCAPE(SZ:300633) 智通财经网·2025-09-05 12:12Group 1 - The company, Kaili Medical, has disclosed a draft for its 2025 restricted stock and stock option incentive plan, proposing to grant 1.914 million shares of the second category of restricted stock and 3.9678 million stock options [1] - The grant price for the second category of restricted stock is set at no less than 15.93 yuan per share, while the exercise price for the stock options is set at no less than 31.86 yuan per option [1] - A total of 406 individuals will be granted under this incentive plan, including certain directors, senior management, middle management personnel, and technical business backbones from the company and its subsidiaries [1] Group 2 - The validity period of the incentive plan will last from the date of granting the second category of restricted stock/stock options until all granted stocks/options are vested, exercised, or become invalid, with a maximum duration of 60 months [1]